Myelin Repair Foundation's Accelerated Research Collaboration™ (ARC™) is a self-sustaining model that spans the entire research process including:
- Identifying the scientific team
- Designing an outcome-driven research plan
- Patenting the discoveries
- Building relationships with biotech and pharmaceutical companies for further discovery, drug development and clinical trials
- Delivering treatments to patients
- Generating income from patent royalties and investing in new research.
The focus of the ARC model: Bridging the gap between academic science and patient treatments.
To learn more about how the ARC model works and what sets it apart from traditional research methods: Download Accelerated Research Collaboration: Driving Discoveries to Treatments (PDF).
ARC Model Components
The ARC model, which can be applied to any medical research problem, has defined components and processes.
Research Focus |
Select a well-defined problem that addresses a critical unmet medical need. |
Labs/Scientists |
Select the most talented and accomplished scientific experts in the areas of expertise required to solve the problem. |
Management |
Provide small highly-efficient and motivated business and scientific support staff supplemented by volunteers. Run organization like a start-up business. |
Scientific Oversight |
Select Scientific Advisory Board of eminent scientists to ensure appropriate design and focus of research plan. |
Business Oversight |
Provide Board of Directors to manage oversight of staff and budget. |
Research Plan |
Work with the scientists to develop an outcome-driven research plan. |
IT Tools |
Connect labs by web-enabled IT infrastructure designed to facilitate daily interaction and data exchanges. |
Communication |
Throughout process, require and facilitate communication and collaboration among those scientific experts for the purpose of providing therapeutics.. |
Shared Intellectual Property |
Work closely with legal counsel, participating university technology transfer offices and scientists to establish relevant patent positions. |
BioPharma Development |
Conduct early discussions with pharmaceutical companies to ensure the rapid development of new therapies. |
Royalty Revenues |
Use income generated from patents to fund future research, creating a self-sustaining research model. |
Find out what makes the Accelerated Research Collaboration model different from traditional medical research.
- Back to top -
